Yun Kong Lin

US Patent:

6841722, Jan 11, 2005

Filed:

Apr 7, 2000

Appl. No.:

09/545072

Inventors:

Yun Lin - Somerville MA, US
Lin Sun - West Roxbury MA, US
Long V. Nguyen - Vacaville CA, US
Howard M. Goodman - Newton MA, US

Assignee:

The General Hospital Corporation - Boston MA

International Classification:

A01H 500
A01H 510
C12H 1529
C12H 1582

US Classification:

800298, 424 932, 4353201, 435419, 4352523, 536 236, 800306

Abstract:

Disclosed is a sse1 gene, which is responsible for protein and oil body biogenesis. The invention further provides methods for using the disclosed gene for modifying the components of plant storage reserve materials.

US Patent:

20070118928, May 24, 2007

Filed:

Nov 21, 2006

Appl. No.:

11/562244

Inventors:

Yun Lin - Savoy IL, US
Shui Wang - Chapel Hill NC, US

International Classification:

A01H 1/00
C12N 15/82
C12N 5/04

US Classification:

800281000, 435419000, 435468000

Abstract:

The present invention relates transgenic plants, progeny, seeds, and vegetatively reproducible structures of plants with reduced or elevated levels of ATP-phosphoribosyl transferase (ATP-PRT) expression or activity. Reduced or elevated levels of ATP-PRT have been found to alter protein or oil content in plants thereby modulating protein-to-oil ratios. Thus, the present invention also embraces a method for altering the protein or oil content of at least one tissue of a plant by modulating the expression or activity of ATP-PRT in the tissue.

US Patent:

20160256550, Sep 8, 2016

Filed:

Feb 26, 2016

Appl. No.:

15/054739

Inventors:

- Hazelwood MO, US
Richard B. Dorshow - St. Louis MO, US
John N. Freskos - Clayton MO, US
Karen L. Wooley - College Station TX, US
Nam S. Lee - College Station TX, US
Yun Lin - College Station TX, US
Guorong Sun - Bryan TX, US

Assignee:

Mallinckrodt LLC - Hazelwood MO
Washington University - St. Louis MO
The Texas A&M University System - College Station TX

International Classification:

A61K 41/00
A61K 31/337
A61K 9/51
A61K 38/08
A61K 31/704
A61K 31/325
A61K 31/055
A61K 49/00
A61K 9/107

Abstract:

The present invention provides optical agents comprising optically functional cross linked supramolecular structures and assemblies useful for tandem optical imaging and therapy. Supramolecular structures and assemblies of the present invention include optically functional shell-cross linked micelles wherein optical functionality is achieved via incorporation of one or more linking groups that include one or more photoactive moieties. The present invention further includes imaging and therapeutic methods using one or more optical agents of the present invention including optically functional shell cross-linked micelles having an associated therapeutic agent.